Keywords
parasitemia
Pfk13 gene
Plasmodium falciparum
children
How to Cite
Abstract
Introduction
Malaria, caused mainly by Plasmodium falciparum in sub-Saharan Africa, remains a major public health concern. It typically manifests as persistent fever and high parasitemia. Of particular concern is the emergence of resistance to artemisinin derivatives, the current reference treatment. Such resistance is often linked to mutations in the Pfk13 gene, recognised as a molecular marker for surveillance. However, clinical, parasitological, and Pfk13 gene data on children under five years of age in Bolenge remain insufficient.
Purpose
To describe the clinical and parasitological profiles and determine the prevalence of the Pfk13 gene in children aged 6–59 months with uncomplicated malaria in Bolenge, DRC.
Methods
This descriptive cross-sectional study was conducted between April 2021 and September 2022, using blood samples collected on filter paper during previous research on the therapeutic efficacy of antimalarial drugs in Bolenge (2017). The study involved 90 children selected through convenience sampling. DNA was extracted from filter paper samples and analysed via classic PCR for Pfk13 mutations. Children included had fever ≥ 37.5 °C and P. falciparum monoinfection with parasitemia between 2,000 and 200,000 trophozoites/μl. Data were analysed using SPSS v20, with descriptive statistics and 95% confidence intervals reported.
Results
The mean age was 43.5 months. A total of 85.6% presented with fever ranging from 37.5–39 °C. Mean parasitemia was 25,000 trophozoites/μl. The Pfk13 gene was detected in 50% (n = 45) of samples, producing 800 bp amplicons.
Conclusion
These results highlight the need to optimise DNA storage and integrate molecular surveillance of Pfk13 into national malaria control policies in Bolenge. Such integration would strengthen the early detection of potential artemisinin resistance and enable the development of targeted therapeutic strategies.
References
Adawaye, C., Kamangu, E., Mahamat Moussa, A., Tchoumbou, B., Vaira, D., Moutschen, M., et al. (2013). Use of dried blood spots to improve HIV diagnosis and management in resource-limited settings. World Journal of AIDS, 3(3), 251–256. http://dx.doi.org/10.4236/wja.2013.33033
Bamadio, A. (2012, March 7). In vivo efficacy of artemether-lumefantrine on Plasmodium falciparum strains and its impact on molecular markers of parasite resistance to antimalarial drugs in Mali [Thesis].
Benoit Vical, F., Paloque, L., & Augereau, J.-M. (2016, March). Resistance of the malaria agent, Plasmodium falciparum, to artemisinin-based combination therapies (ACTs): Fears of widespread chemoresistance [Article in French]. Bulletin of the National Academy of Medicine, 200(3), 477–489; discussion 490.
Coulibaly, B. N. (2012). Malaria in children under 5 years of age in the pediatric ward of the reference health center in Commune I of the Bamako district [Thesis].
Dorkenoo, A. M., Yehadji, D., Agbo, Y. M., Layibo, Y., Agbeko, F., Adjeloh, P., Yakpa, K., Sossou, E., Awokou, F., & Ringwald, P. (2016). Trial of the therapeutic efficacy of artemisinin-based combination therapies for the treatment of uncomplicated malaria and study of mutations in the k13 propeller domain in Togo, 2012–2013. Malaria Journal, 15, 331. https://doi.org/10.1186/s12936-016-1381-8
Doudou, M., Nsibu, C. N., Kabamba, J., et al. (2020). Clinical and parasitological profile of uncomplicated malaria in children in Kinshasa. Revue Médicale et Pharmaceutique d'Afrique, 34(2), 103–110.
Gbaguidi, G., Issaka, B., Gado, T., et al. (2014). Malaria infection in pregnant women in Niamey, Niger. The Pan African Medical Journal, 17(Suppl 1), 1–7. https://pmc.ncbi.nlm.nih.gov/articles/PMC7992404
Jena Bioscience. (2015). Technical data sheet for blood, animal, and plant DNA preparation kit, genomic DNA purification by centrifugation column.
Maiga Souleymane, M. (2019). Study of mutations in the genetic background of Plasmodium falciparum resistance to artemisinin in two locations with different endemicity in Mali: Nioro du Sahel and Dangassa [Thesis].
Mbengue, A., Bhattacharjee, S., Pandharkar, T., Liu, H., Estiu, G., Stahelin, R. V., et al. (2015). Molecular mechanism of artemisinin resistance in Plasmodium falciparum. Science, 348(6240), 1206–1211. https://doi.org/10.1126/science.1261505
Ministry of Public Health. (2021). National Health Development Plan 2021–2025 (PNDS).
Ministry of Public Health, Hygiene, and Prevention. (2023). DRC Health Statistics Yearbook 2022.
Moriarty, L. F., Mandoko, N. P., Losimba, L. J., Mitashi, M. P., Mukomena, S. E., Matangila, R. J., et al. (2021). Therapeutic efficacy of artemisinin-based combination therapies in the DRC and study of molecular markers of resistance. The American Journal of Tropical Medicine and Hygiene. https://doi.org/10.4269/ajtmh.210214
Mukadi, P. M., Ntamabyaliro, N., Mutombo, P., Kayembe, J., Nsangi, B., & Kalenda, D. (2021). Patterns of malaria infection in the north-western region of the Democratic Republic of Congo. Journal of Infection and Public Health, 14(8), 1037–1044. https://doi.org/10.1016/j.jiph.2021.06.014
Mukomena, S. E., Philipe, C. M., Désiré, M. K., Tshindele, P. L., Ali, M. M., & Numbi, O. L. (2016). Asymptomatic parasitemia in children under five, school-age children, and home self-medication, Lubumbashi, Democratic Republic of Congo. The Pan African Medical Journal, 24, 94. https://doi.org/10.11604/pamj.2016.24.94.9350
Mutombo, A. M., Kamona, Y. M., Tshibanda, C. N., Mukuku, O., Ngwej, D. T., Wembonyama, S. O., Luboya, O. N., & Lutumba, P. (2018). Severe malaria in children under 5 years of age at Panda Hospital in Likasi, Democratic Republic of Congo. Revue de l’Infirmier Congolais, 2(2), 4–10.
Mvumbi Makaba, D. (2017). The role of molecular biology in the epidemiology, diagnosis, and evaluation of malaria chemoresistance in the Democratic Republic of Congo [Doctoral thesis, University of Kinshasa].
Nag, S., Ursing, J., Rodrigues, A., Crespo, M., Krogsgaard, C., Lund, O., Aarestrup, F. M., Alifrangis, M., & Kofoed, P. E. (2019). Proof of concept: Rapid malaria diagnostic tests used for parallel sequencing to monitor molecular markers of antimalarial resistance in Bissau, Guinea-Bissau, between 2014 and 2017. Malaria Journal, 18, 252. https://doi.org/10.1186/s12936-019-2894-8
National Malaria Control Program. (2024). Annual activity report 2023. Ministry of Public Health, Hygiene, and Prevention, DRC.
National Malaria Control Program (PNLP). (2025, April 24). DRC: 21,695 malaria-related deaths recorded in 2024. ACP. https://acp.cd/sante/rdc-21695-deces-lies-a-la-malaria-enregistres-au-cours-de-lannee-2024-programme-national-de-lutte-contre-le-paludisme/
Ngweme, G. N., Situakibanza, H. N., Losimba, L., Mupenda, B., Kayembe, N., Madinga, J., & Kalonji, A. (2019). Prevalence and risk factors of malaria infection in rural health zones of Equateur Province, DRC. Tropical Medicine and Health, 47, 44. https://doi.org/10.1186/s41182-019-0175-4
Sanogo, M. A. L. (2021, October 21). Morbidity and mortality related to severe malaria in children aged 6 to 59 months in the pediatric ward of the CS ref in Sikasso [Thesis, USTTB, Mali].
Schmedes, S. E., Patel, D., Dhal, S., Kelley, J., Svigel, S. S., Dimbu, P. R., Adeothy, A.-L., Kahunu, G. M., Nkoli, P. M., Beavogui, A. H., Kariuki, S., Mathanga, D. P., Koita, O., Ishengoma, D., Mohamad, A., Hawela, M., Moriarty, L. F., Samuels, A. M., Gutman, J., Plucinski, M. M., Udhayakumar, V., Zhou, Z., Lucchi, N. W., Venkatesan, M., Halsey, E. S., & Talundzic, E. (2021, July). Plasmodium falciparum kelch13 gene mutations, 9 African countries, 2014–2018. Emerging Infectious Diseases, 27(7), 1902–1908. https://doi.org/10.3201/eid2707.203230
Soumaré, T. (2021). Management of malaria in children aged 0 to 59 months at the Yirimadio Community Health Center (CSCom) [Thesis, University of Science, Technology, and Technology of Bamako].
Uwimana, A., Legrand, E., Stokes, B. H., Ndikumana, J. M., Warsame, M., Umulisa, N., et al. (2020). Emergence and clonal expansion of artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda. The Lancet Infectious Diseases, 20(8), 915–921. https://doi.org/10.1016/S1473-3099(20)30260-4
van Loon, W., Schallenberg, E., Igiraneza, C., Habarugira, F., Mbarushimana, D., Nshimiyimana, F., Ngarambe, C., Ntihumbya, J. B., Ndoli, J. M., & Mockenhaupt, F. P. (2023). Increased prevalence of the Plasmodium falciparum K13 marker indicating artemisinin resistance in southern Rwanda. Antimicrobial Agents and Chemotherapy, 68(1), e01299-23. https://doi.org/10.1128/aac.01299-23
World Health Organization. (2020). Report on the effectiveness, resistance, and response to antimalarial drugs (2010–2019).
World Health Organization. (2022). Guidelines for the treatment of malaria (3rd ed.). https://www.who.int/publications/i/item/9789240045311
World Health Organization. (2023). Guidelines for the treatment of malaria (3rd ed.).
World Health Organization. (2023). World malaria report 2023. https://www.who.int/publications/i/item/9789240076680
World Health Organization. (2025). Malaria – Key facts. https://www.who.int/news-room/fact-sheets/detail/malaria
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.